Concepedia

Zi Chen

ZC

Statistics

Publications

2

Citations

51

H-Index

2

Active since

2023

Affiliations

Sun Yat-sen University Cancer Center(Current)

Sun Yat-sen University

Zi Chen is an author at Sun Yat-sen University Cancer Center specializing in chronic lymphocytic leukemia therapy, chemotherapy, and hematologic malignancy pharmacotherapy.

ORCID

Publications per year

2023–2024

2

Publications

2

Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial

Sikander Ailawadhi, Zi Chen, Bo Huang et al. · Clinical Cancer Research · 2023 · 38 citations · Full text

, , +17

Updated efficacy results of olverembatinib (HQP1351) in patients with tyrosine kinase inhibitor (TKI)-resistant succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors (GIST) and paraganglioma.

Haibo Qiu, Zhiwei Zhou, Ye Zhou et al. · Journal of Clinical Oncology · 2024 · 13 citations

, , +13

1–2 of 2